These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 8639672

  • 1. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.
    Cacia J, Keck R, Presta LG, Frenz J.
    Biochemistry; 1996 Feb 13; 35(6):1897-903. PubMed ID: 8639672
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H, Nie Y, Huse WD, Watkins JD.
    J Mol Biol; 1999 Nov 19; 294(1):151-62. PubMed ID: 10556035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B, Knittelfelder R, Wallmann J, Krieger S, Szalai K, Untersmayr E, Vogel M, Stadler BM, Scheiner O, Boltz-Nitulescu G, Jensen-Jarolim E.
    Mol Immunol; 2006 Jul 19; 43(14):2180-7. PubMed ID: 16510185
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC, Shan L, Goldsteen BZ, Guddat LW, Thakur A, Landolfi NF, Co MS, Vasquez M, Queen C, Ramsland PA, Edmundson AB.
    J Mol Recognit; 1999 Jul 19; 12(1):19-32. PubMed ID: 10398393
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.
    Saviranta PJauria P, Lamminmäki U, Hellman J, Eriksson S, Lövgren T.
    Protein Sci; 2000 Dec 19; 9(12):2547-56. PubMed ID: 11206076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA, Boriack-Sjodin PA, Day E, Eldredge J, Fitch C, Jarpe M, Miller S, Li Y, Simon K, van Vlijmen HW.
    Protein Eng Des Sel; 2009 Feb 19; 22(2):93-101. PubMed ID: 19074157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X, Campoli M, Ko E, Luo W, Ferrone S.
    J Immunol Methods; 2004 Nov 19; 294(1-2):23-35. PubMed ID: 15604013
    [Abstract] [Full Text] [Related]

  • 20. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS, Air GM.
    Biochemistry; 1998 Jul 28; 37(30):10660-70. PubMed ID: 9692956
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.